What does Identiv do and what are its main business segments?

What is Identiv's gross profit margin?

What is the revenue and EPS growth rate for Identiv year over year?

What is Identiv's latest dividend and current dividend yield?

What were the key takeaways from Identiv's earnings call?

What were the key takeaways from Identiv’s earnings call?

What guidance did Identiv's management provide for the next earnings period?

What factors drove the changes in Identiv's revenue and profit?

- **Strategic Win**: IFCO multiyear agreement for 100M+ BLE labels annually, with ASP $0.15-$1.00 and exclusive supply.
- **Operational Turnaround**: Q4 2025 non-GAAP gross margin 25.6%, up 17.6% YoY from Singapore shutdown and Thailand efficiency.
- **Growth Catalysts**: 2026 Q1 revenue +26%-35% YoY, with IFCO ramp and 29 new pipeline conversions to $1.2M in 2025.
- **Risk Management**: 2026 gross margin variability from production scaling, but 30%+ long-term target via high-margin NPDs and Thailand cost structure.

**【CEO Summary Section】**
- **Revenue Growth and Strategic Wins**: Q4 2025 revenue of $6.2 million exceeded guidance, driven by the completion of the Singapore to Thailand manufacturing transition. The company signed a multiyear agreement with IFCO for BLE smart labels, targeting 100 million units annually by 2026.
- **Operational Efficiency**: Gross margin improved to 25.6% (non-GAAP) due to reduced costs from Singapore shutdown and Thailand facility optimization. New CRM and MRP systems enhance demand forecasting and inventory management.
- **Pipeline and Innovation**: 101 new sales pipeline opportunities (up 35% YoY), with 29 converted to $1.2 million in revenue. Focus on high-margin segments like healthcare, logistics, and food safety, with 5 new product developments completed in 2025.

**【CFO Financial Commentary】**
- **Financial Highlights**: Q4 2025 GAAP net loss narrowed to $3.7 million (-14% YoY), with non-GAAP EBITDA loss of $2.5 million (improving 44% YoY). FY2025 cash balance of $128.9 million supports 2026 growth initiatives.
- **2026 Outlook**: Q1 revenue guidance of $6.7-$7.2 million (+26%-35% YoY), with IFCO and new customer ramps expected to drive growth. Gross margin variability in early 2026 due to production scaling, but long-term margin expansion anticipated.

**【Q&A Highlights】**
- **IFCO Deal Details**: Exclusive supplier for IFCO's 400M+ reusable containers, with ASP between $0.15 and $1.00. Gross margin target is below 30% but higher than legacy products. Full production ramp in Q4 2026.
- **Pipeline Breakdown**: 25% of pipeline in healthcare, 25% logistics, 25% food/beverage, and 25% other. 2/3 of NPD projects target >30% gross margin.
- **Gross Margin Drivers**: 2026 variability from IFCO and new customer ramps, but long-term margin expansion via Thailand efficiency and high-margin NPDs.

Identiv, Inc.(INVE)-20260313-2025 Q4 Earnings call transcript

- **Thailand Transition Success**: 100% production in Thailand drives 19.1% non-GAAP gross margin (vs. 9.3% YoY). 
- **BLE Momentum**: IFCO and Wiliot projects entering field testing. 
- **Pipeline Growth**: 18% new sales conversion, 17 active NPD projects. 
- **Cost Efficiency**: $3.6M adj. EBITDA loss (vs. $4.5M YoY).

**【CEO Opening Remarks】**
- Q3 2025 revenue of $5.0 million met guidance, with 100% production now in Thailand, driving 19.1% non-GAAP gross margin (vs. 9.3% YoY). Singapore shutdown complete by year-end, reducing costs and improving scalability. New BLE projects with IFCO and Wiliot show early commercial traction. 

**【CFO Financial Commentary】**
- Q3 2025 GAAP net loss $3.5M (-67% YoY) due to lower strategic costs. Non-GAAP adj. EBITDA loss $3.6M (vs. $4.5M YoY) from Thailand efficiency gains. Q4 2025 revenue guidance $5.4-5.9M (+11% QoQ) driven by BLE and channel growth. 

**【Strategic Initiatives Update】**
- 17 active NPD projects (43% health care/BLE), 3 Q3 completions for anti-counterfeiting in luxury spirits. 18% new pipeline conversion (10% Q3 sales). Thailand MRP/CMS implementations nearing completion. 

**【Q&A Highlights】**
- IFCO BLE prototypes in field testing; Wiliot next-gen pixels shipping Q3. 2/3 new sales >30% margin. 2026 BLE volume ramp expected. Singapore shutdown costs tailwind Q4. 

**【Financials】**
- Q3 2025: 
  - Revenue $5.0M (-23% YoY) due to margin focus. 
  - Gross margin 19.1% (vs. 9.3% YoY). 
  - Q4 2025 guidance $5.4-5.9M (+11% QoQ).

Identiv, Inc. (INVE) Q3 2025 Earnings Call Transcript

- **Revenue decline**: Q2 2025 revenue $5M (-25% YoY), driven by lower RFID sales and customer inventory reduction.
- **Strategic BLE growth**: 400M+ RPC tagging partnership with IFCO, targeting 2026 mass production.
- **Gross margin recovery**: Singapore production closure to improve margins in H2 2025.
- **M&A focus**: Evaluating strategic alternatives with Raymond James to accelerate growth.

**【CEO Opening Remarks】**
- Announced Ed Kirnbauer as permanent CFO, highlighting his 10+ years of experience at Identiv.
- Q2 revenue: $5 million (within guidance), down 25% YoY due to lower RFID sales and reduced orders from largest customer.
- Key trends: Strong demand for BLE and IoT solutions, 400M+ RPC tagging partnership with IFCO (targeting 2026 mass production).
- Risks: U.S.-Thailand tariffs (19% on Thai imports) and increased competition in standard products.

**【CFO Financial Commentary】**
- Q2 GAAP net loss: $6.0M (-26% YoY), driven by $1.6M one-time costs in 2024.
- Gross margin: -9.4% GAAP, -0.8% non-GAAP (vs. 9.1% and 14.6% YoY), impacted by Singapore-Thailand transition costs.
- Operating expenses: $5.9M GAAP (-19% YoY), $4.5M non-GAAP (-3% YoY), reflecting cost control.
- Cash position: $129.6M, with Q3 2025 revenue guidance of $4.8-5.2M.

**【Strategic Framework Update】**
1. **Perform (Core Channel)**:
   - 33% increase in new sales pipeline opportunities.
   - 300% YoY growth in website RFIs due to 22 marketing initiatives.
   - Singapore production fully transitioned to Thailand, with site closure by end-2025.
2. **Accelerate (High-Value Apps)**:
   - BLE smart labels for IFCO RPCs, Wiliot IoT Pixels, and InPlay smart labels (late 2025 launch).
   - 19 active NPD projects (4 health care, 5 BLE-based).
3. **Transform (M&A)**:
   - Evaluating strategic alternatives with Raymond James; new Board member Mick Lopez added for M&A expertise.
   - Metrics: 100 new pipeline opportunities (14% conversion rate), 1 NPD project completed in Q2.

**【Q&A Highlights】**
- **IFCO Partnership**: 400M+ RPC tagging over 4-5 years, with 10%+ annual replenishment.
- **Gross Margin Outlook**: Positive impact from Singapore closure, targeting margin improvement in H2 2025.
- **Order Patterns**: Q3 order flow consistent with guidance, no major deviations noted.

Identiv, Inc. (INVE) Q2 2025 Earnings Call Transcript

- **Strategic Transition Progress**: 75%+ production shifted to Thailand, with Q2 completion of Singapore exit.
- **BLE Growth Catalysts**: 5 BLE-based NPD projects in pipeline, partnerships with Tag-N-Trac and InPlay.
- **Risk Management**: $4.8M net loss reflects tariff-related costs, but $132M+ cash provides liquidity buffer.
- **Guidance Caution**: Deferred Q4 gross margin guidance due to 90-day tariff review uncertainty.
- **Pipeline Momentum**: 74 new opportunities in Q1, 10% conversion rate, targeting 12-month rolling metrics.

**【CEO Opening Remarks】**
- Q1 2025 net revenue of $5.3M, slightly above guidance, with a 21% YoY decline driven by exit of low-margin business.
- 25% of revenue exposed to US import tariffs; production transition to Thailand complete by Q2 end.
- Strategic focus on RFID and BLE solutions for IoT, with partnerships in pharmaceutical cold chain and smart logistics.

**【CFO Financial Highlights】**
- GAAP net loss: $4.8M (-11% YoY), Non-GAAP adj. EBITDA: -$3.9M (vs. -$3.2M YoY).
- Gross margin: 10.8% (Non-GAAP) vs. 13.4% YoY, impacted by dual manufacturing costs.
- Operating expenses: $4.5M (Non-GAAP) +10% YoY due to R&D and sales investments.
- Cash balance: $132.7M, with $14-16M annual cash use guidance.

**【Strategic Framework Progress】**
1. **Perform (Core Business)**:
   - 74 new pipeline opportunities, 10% converted in Q1.
   - 21 active NPD projects (13 customer-driven, 8 internal).
   - Transition to Thailand reducing costs by ~27% in H2.
2. **Accelerate (High-Value Apps)**:
   - BLE partnerships with Tag-N-Trac (pharma cold chain) and InPlay (logistics).
   - 3 healthcare, 3 consumer/logistics growth initiatives.
3. **Transform (M&A)**:
   - Active M&A discussions; metrics for tracking pipeline and NPD progress established.

**【Q&A Key Takeaways】**
- Tariffs: 25% of revenue impacted; surcharge strategy in place, but demand uncertainty persists.
- Grocery logistics deal: Trial in Q4 2025, full launch mid-2026.
- Gross margin guidance: Deferred due to tariff review uncertainty.
- No Q1 pull-in orders; Q2 bookings stable despite macro caution.

Identiv (INVE)-7 May 25-2025 Q1 Earnings call transcript

- **Revenue Beat**: Q4 2024 revenue $6.7M (+$600K vs. guidance) driven by customer acceleration ahead of production transition.
- **Gross Margin Roadmap**: Q4 2025 target 26-28%; long-term 35%. Final 3 low-margin customers transitioning Q2 2025.
- **Strategic Momentum**: 
  - New BLE partnership with Novanta for medical device authentication
  - LOI with grocery logistics leader for $100M+ pallet monitoring solution
  - $135M+ cash position to fund M&A and growth
- **Risk Management**: Maintaining tight OpEx control; 2025 cash use $14-16M.

**【CEO Opening Remarks】**
- **Business Transformation**: Post-physical security business sale, Identiv is now a pure-play specialty RFID and BLE solutions provider. Q4 2024 revenue exceeded guidance by $600K due to a customer accelerating delivery ahead of Singapore-to-Thailand production transition.
- **PAT Strategic Framework**: Focus on **Perform** (core channel growth), **Accelerate** (high-value IoT applications), and **Transform** (M&A for scale). New commercial leader Kim McCauley and health care biz dev lead Deepak Prakash have been hired to drive execution.
- **Production Transition**: 75% of Singapore volume moved to Thailand by end-2024; final 3 low-margin customers expected to transition by Q2 2025. Long-term non-GAAP gross margin target: 35%.

**【CFO Financial Review】**
- **Q4 2024 Results**: 
  - Revenue: $6.7M (vs. $6.1M guidance midpoint)
  - GAAP Net Loss: $4.3M (-14.9% gross margin)
  - Non-GAAP EBITDA: -$4.5M
  - Cash: $135.9M (up $111M YoY from strategic transaction proceeds)
- **FY 2024 Highlights**: 
  - Revenue: $26.6M (down 38% YoY)
  - GAAP Gross Margin: 1.3% (vs. 13.8% prior year)
  - Non-GAAP OpEx: $17.9M (up 6% YoY)
- **2025 Outlook**: Q1 revenue $4.8-5.1M; 2025 cash use $14-16M.

**【CEO Business Updates】**
- **New Product Development**: 
  - BLE smart labels for pharma cold chain, reusable food containers
  - HF inlays ID Safe and IDT with NXP ICO3 IC
  - LOI with grocery logistics leader for BLE-enabled pallet monitoring
- **Partnerships**: 
  - Novanta collaboration for medical device consumable authentication
  - BLE R&D expansion with new product manager/engineer hires
- **M&A Pipeline**: 100+ targets evaluated; focused on scale, technical capability, and Thailand utilization.

**【Q&A Highlights】**
- **Gross Margin Path**: Q4 2025 target 26-28%; long-term 35%. 2025 OpEx expected to rise slightly with new hires.
- **Customer Transition**: No revenue disruption; final 3 customers (low-margin) transitioning Q1-2025.
- **BLE Opportunity**: ASP > corporate average; first volumes expected late 2025 for pallet monitoring solution.
- **Breakeven Timing**: No formal guidance; focus on 2026+ growth from 2025 NPD pipeline.

Actual												-0.13	-0.17	0.01	-0.05	-0.09	0.09	0.09	-0.1	-0.06	-0.02	0.01	0	-0.13	-0.06	-0.01	-0.08	-0.21	-0.27	3.62	-0.11	-0.21	-0.26	-0.15	-0.16
Forecast												-0.12	-0.095	0.0033	-0.0467	-0.105	-0.04	0.06	0.03	-0.084	-0.02	0.064	-0.004	-0.0625	-0.0625	0.02	-0.0333	-0.1533	-0.1867	-0.2467	-0.2867	-0.2167	-0.2467	-0.2167	-0.1667
Surprise	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-8.33%	-78.95%	+203.03%	-7.07%	+14.29%	+325.00%	+50.00%	-433.33%	+28.57%	0.00%	-84.38%	+100.00%	-108.00%	+4.00%	-150.00%	-140.24%	-36.99%	-44.62%	+1567.37%	+61.63%	+3.09%	-5.39%	+30.78%	+4.02%

INVE

INVE fundamentals

INVE Q4 2025 Earnings

Earnings Call

You can ask Aime

INVE

INVE fundamentals

INVE Q4 2025 Earnings

Earnings Call

INVE Earnings Call Summary for Q4/20255:00 PM on Mar 12, 2026

INVE Earnings Call Summary for Q3/20255:00 PM on Nov 10, 2025

INVE Earnings Call Summary for Q2/20255:00 PM on Aug 7, 2025

INVE Earnings Call Summary for Q1/20255:00 PM on May 7, 2025

INVE Earnings Call Summary for Q4/20245:00 PM on Mar 5, 2025

You can ask Aime